LX1
LX1 is a small molecule research compound that targets prostate cancer by inhibiting AKR1C3, suppressing AR and AR-V7 expression, and blocking androgen synthesis. It overcomes Enzalutamide resistance and shows synergistic anti-tumor effects in combination therapy in preclinical models.
Product Specifications
CAS Number
2647877-84-5
Field of Research
Metabolism Research
Smiles
O=C (NC=1C=C (C=C (C1) C (F) (F) F) C (F) (F) F) C2=CC (=CC=C2O) CC=3C=CC=CC3
Molecular Formula
C22H15F6NO2
Molecular Weight
439.35
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A18284-Biotin 100 µg/Vial
Anti-SPINK13 Antibody Picoband® (Biotine Conjugate)
Sign In for Pricing
View Details 